Pages

Wednesday, 8 May 2019

Jazz Pharmaceuticals Hits All the Right Notes in Q1


Jazz Pharmaceuticals Hits All the Right Notes in Q1



The drugmaker reported strong revenue and earnings growth thanks largely to solid growth for narcolepsy drug Xyrem.

No comments:

Post a Comment